HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuya Yamamoto Selected Research

Carteolol (Carteolol Hydrochloride)

11/2016Randomized, Controlled, Phase 3 Trials of Carteolol/Latanoprost Fixed Combination in Primary Open-Angle Glaucoma or Ocular Hypertension.
6/2007[Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuya Yamamoto Research Topics

Disease

91Neoplasms (Cancer)
04/2022 - 01/2002
31Glaucoma
01/2021 - 01/2002
27Glioma (Gliomas)
01/2022 - 07/2009
23Glioblastoma (Glioblastoma Multiforme)
06/2019 - 08/2007
22Hyperuricemia
01/2022 - 01/2004
21Gout
01/2021 - 07/2002
17Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2018 - 01/2002
15Brain Neoplasms (Brain Tumor)
11/2021 - 01/2002
13Insulin Resistance
01/2022 - 06/2005
13Low Tension Glaucoma
01/2020 - 01/2002
12Squamous Cell Carcinoma of Head and Neck
02/2022 - 01/2003
12Body Weight (Weight, Body)
01/2021 - 04/2002
11Blister (Bulla)
01/2021 - 01/2009
9Inflammation (Inflammations)
01/2021 - 11/2005
9Infections
01/2020 - 10/2009
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 02/2003
8Hypoxia (Hypoxemia)
01/2019 - 07/2005
7Carcinoma (Carcinomatosis)
04/2021 - 01/2003
6Hemorrhage
06/2022 - 08/2005
6Lymphoma (Lymphomas)
07/2021 - 06/2010
6Mouth Neoplasms (Oral Cancer)
08/2020 - 09/2004
6Ocular Hypertension (Glaucoma, Suspect)
11/2016 - 06/2007
5Atherosclerosis
01/2022 - 01/2004
5Type 2 Diabetes Mellitus (MODY)
09/2021 - 05/2003
5Disease Progression
04/2021 - 11/2007
5Ganglion Cysts (Ganglion)
01/2020 - 10/2004
5Necrosis
07/2018 - 09/2003
4Epilepsy (Aura)
01/2022 - 01/2021
4Obesity
01/2022 - 06/2005
4Pathologic Constriction (Stenosis)
10/2021 - 11/2007
4Astrocytoma (Pilocytic Astrocytoma)
01/2021 - 04/2011
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 09/2013
4Neoplasm Metastasis (Metastasis)
12/2020 - 01/2011
4Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 11/2006
4Aneurysm (Aneurysms)
09/2019 - 06/2017
4Chronic Renal Insufficiency
12/2018 - 01/2014
4Breast Neoplasms (Breast Cancer)
11/2018 - 07/2002
4Brain Edema (Cerebral Edema)
07/2017 - 01/2009
4Edema (Dropsy)
06/2017 - 08/2005
4Blindness (Hysterical Blindness)
06/2015 - 01/2010

Drug/Important Bio-Agent (IBA)

33Uric Acid (Urate)IBA
01/2022 - 04/2002
17Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
17Retinaldehyde (Retinal)IBA
01/2020 - 01/2002
12Pharmaceutical PreparationsIBA
01/2021 - 06/2007
12Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 01/2010
11purineIBA
01/2022 - 09/2003
10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 10/2003
10Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2016 - 06/2002
10Xanthine OxidaseIBA
12/2014 - 09/2003
9Insulin (Novolin)FDA Link
05/2021 - 06/2008
9FebuxostatFDA Link
12/2018 - 06/2011
9Allopurinol (Remid)FDA LinkGeneric
06/2011 - 07/2002
8Glucose (Dextrose)FDA LinkGeneric
05/2021 - 04/2012
8TeaIBA
05/2014 - 07/2003
8PolyphenolsIBA
05/2014 - 07/2003
6CytokinesIBA
10/2021 - 01/2003
6SodiumIBA
05/2021 - 06/2004
6Messenger RNA (mRNA)IBA
01/2021 - 03/2005
6Biomarkers (Surrogate Marker)IBA
12/2020 - 03/2011
6Bevacizumab (Avastin)FDA Link
07/2018 - 01/2013
6Cancer VaccinesIBA
01/2018 - 08/2007
6Formaldehyde (Formol)FDA Link
01/2018 - 07/2002
6AntioxidantsIBA
01/2017 - 01/2003
6UridineIBA
06/2010 - 04/2002
5AntibodiesIBA
12/2020 - 11/2005
5Peptides (Polypeptides)IBA
06/2019 - 11/2004
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2017 - 01/2012
5Latanoprost (Xalatan)FDA Link
11/2016 - 01/2006
5Carmustine (FIVB)FDA Link
07/2016 - 11/2013
5K-115IBA
02/2016 - 10/2013
5HypoxanthineIBA
01/2015 - 09/2003
5epigallocatechin gallate (epigallocatechin-3-gallate)IBA
05/2014 - 07/2003
5AutoantibodiesIBA
07/2011 - 01/2004
4Biological ProductsIBA
01/2022 - 07/2002
4Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021 - 04/2011
4SteroidsIBA
01/2019 - 01/2013
4Ethanol (Ethyl Alcohol)IBA
10/2018 - 10/2002
4VaccinesIBA
01/2018 - 08/2007
4LigandsIBA
06/2017 - 10/2008
4Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 10/2009
4Hydrocortisone (Cortisol)FDA LinkGeneric
12/2016 - 01/2013
4GadoliniumIBA
05/2016 - 01/2002
4rho-Associated KinasesIBA
02/2016 - 10/2013
4Protons (Proton)IBA
03/2014 - 07/2009
4Superoxide DismutaseIBA
05/2010 - 02/2003
4BoronIBA
07/2009 - 04/2008
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2008 - 05/2003
4Interleukin-6 (Interleukin 6)IBA
01/2006 - 01/2003

Therapy/Procedure

50Therapeutics
12/2022 - 01/2003
31Radiotherapy
06/2022 - 10/2003
23Drug Therapy (Chemotherapy)
04/2022 - 10/2006
16Trabeculectomy (Trabeculoplasty)
01/2021 - 04/2006
8Proton Therapy
11/2021 - 03/2014
8Boron Neutron Capture Therapy
03/2018 - 11/2004
8Chemoradiotherapy
06/2017 - 03/2003
6Filtering Surgery
01/2021 - 09/2007
5Immunotherapy
07/2017 - 01/2003
5Lasers (Laser)
03/2012 - 01/2002
4Decompression
11/2020 - 10/2018
3Stents
12/2022 - 06/2017